Orphan products: an emerging trend in drug approvals

被引:29
作者
Cote, Timothy [1 ]
Kelkar, Aditya [1 ,2 ]
Xu, Kui [1 ]
Braun, M. Miles [1 ]
Phillips, M. Ian [2 ]
机构
[1] US FDA, Off Orphan Prod Dev, Rockville, MD 20857 USA
[2] Keck Grad Inst, Claremont, CA 91711 USA
关键词
D O I
10.1038/nrd2546-c1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:84 / U11
页数:2
相关论文
共 7 条
[1]  
[Anonymous], SEARCH ORPH DRUG DES
[2]  
*FOOD DRUG ADM, ORPH DRUG ACT
[3]   Focus on research - Adopting orphan drugs - Two dozen years of treating rare diseases [J].
Haffner, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05) :445-447
[4]  
Hughes B., 2008, NAT REV DRUG DISCOV, V7, P190
[5]  
*NAT ORG RAR DIS, AB NORD
[6]   Market incentives and pharmaceutical innovation [J].
Yin, Wesley .
JOURNAL OF HEALTH ECONOMICS, 2008, 27 (04) :1060-1077
[7]  
NME DRUG NEW BIOL AP